Principal Investigator
Terrence Bradley
Enrollment Status
Open
Clinical Trial ID
Institutional Protocol #
20220775
Clinical Trial Summary
A Phase I/2, Open-label, Dose-escalation, Safety, Pharmacokinetic, and Pharmacodynamic Study of Oral TP-3654 in Patients with Intermediate or High-risk Primary or Secondary Myelofibrosis
Phase
Phase I/II
Funding Agency/Sponsor
Industrial
Disease
Leukemia/heme
Contact Information
Phone Number
305-243-2647